Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PRNP | P04156 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.36 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TACR1 | P25103 | 2/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5556537 | 0.94 | ACHE (0.40) | ACHEMEN1KMT2APRNPPPARG | |
| SCHEMBL30662429 | 0.89 | ACHE (0.46) | ACHEALDH1A1TACR1ESR2MAPT | |
| SCHEMBL27568153 | 0.85 | ACHE (0.48) | ACHETACR1ESR2MAPTMAPK1 | |
| SCHEMBL5556083 | 0.81 | KDM4E (0.42) | ACHEMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12415333 | 0.79 | ESR1 (0.40) | ACHEMEN1KMT2AALDH1A1TACR1 | |
| SCHEMBL7694531 | 0.77 | ACHE (0.41) | ACHEALDH1A1TACR1ESR2MAPT | |
| SCHEMBL4586367 | 0.76 | TSHR (0.40) | ALDH1A1MAPK1 | |
| SCHEMBL1155242 | 0.76 | ESR1 (0.53) | ACHEMEN1KMT2AALDH1A1ESR2 | |
| SCHEMBL30307751 | 0.76 | ALDH1A1 (0.41) | ACHEMEN1KMT2AALDH1A1ESR2 | |
| SCHEMBL25625149 | 0.76 | MAPK1 (0.41) | ACHEMEN1KMT2AALDH1A1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | CYP1A1, AHR, CYP2C9 | ACHE 954/4885MEN1 1232/4885KMT2A 1086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.